CliffBio
small molecule

SUTAB

MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE

Loss of exclusivityAugust 2037latest FDA-listed patent expiry
CompanyAzurity Pharmaceuticals →View the full company profile on CliffBio

Drug detail

Brand nameSUTAB
Active ingredientMAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE
Strength0.225GM;0.188GM;1.479GM
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2020
Marketing statusRX

Listed patents

PatentExpiresType
11382864August 2037use U-3164
11033498August 2037use U-3164
11638697August 2037product
10143656August 2037product

More from Azurity Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Not found